This NGS-based genetic panel evaluates genes associated with congenital neutropenia, a group of inherited disorders characterized by persistently low neutrophil counts. Metropolis Healthcare uses high-depth sequencing to detect pathogenic variants that impair neutrophil production or function. The test helps clarify the underlying cause of chronic or recurrent infections and guides long-term clinical management. A blood sample collected in an EDTA vial is required for testing.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0181
Frequently Asked Questions (FAQ's):
What does the Congenital Neutropenia Gene Panel include at Metropolis Healthcare?
It includes targeted sequencing of multiple genes known to cause different forms of congenital neutropenia.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses advanced Next-Generation Sequencing with detailed bioinformatic analysis to identify disease-causing variants.
Who should consider taking this test at Metropolis Healthcare?
Individuals with chronic low neutrophil counts, recurrent infections, or a family history of neutropenia should consider this test.
What type of sample does Metropolis Healthcare require for this panel?
A blood sample collected in an EDTA tube is needed for the sequencing process.
How can this test help in treatment planning?
It identifies the genetic subtype, helping clinicians tailor management, infection prevention, and monitoring strategies.
How long does Metropolis Healthcare take to provide the report?
The typical turnaround time is 2–4 weeks depending on the gene complexity.
Can this test detect carriers of congenital neutropenia?
Yes, the panel can identify carriers, which is useful for family planning and risk assessment.
Is genetic counseling recommended after testing at Metropolis Healthcare?
Yes, counseling helps interpret results and understand inheritance patterns and future risks.